Deals this week: Rosetta Genomics, Enamine, Wuxi Biologics

Rosetta Genomics and Sheba Medical Centre have entered a research agreement to develop and evaluate the efficacy of microRNA biomarkers to analyse the response of the drug nivolumab in lung cancer patients.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news